MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Search

Stevanato Group SpA

Fechado

SetorSaúde

13.66 -0.36

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.08

Máximo

13.89

Indicadores-chave

By Trading Economics

Rendimento

-2M

47M

Vendas

40M

343M

P/E

Médio do Setor

22.831

56.063

Margem de lucro

13.738

Funcionários

6,010

EBITDA

18M

90M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+78.18% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-442M

3.7B

Abertura anterior

14.02

Fecho anterior

13.66

Sentimento de Notícias

By Acuity

50%

50%

163 / 349 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de abr. de 2026, 22:56 UTC

Notícias Principais

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 de abr. de 2026, 20:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 de abr. de 2026, 23:55 UTC

Conversa de Mercado

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 de abr. de 2026, 23:23 UTC

Notícias Principais

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 de abr. de 2026, 23:07 UTC

Ganhos

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 de abr. de 2026, 23:02 UTC

Notícias Principais

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 de abr. de 2026, 22:39 UTC

Ganhos

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 de abr. de 2026, 22:08 UTC

Conversa de Mercado

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 de abr. de 2026, 22:00 UTC

Notícias Principais

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 de abr. de 2026, 22:00 UTC

Notícias Principais

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 de abr. de 2026, 21:56 UTC

Aquisições, Fusões, Aquisições de Empresas

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 de abr. de 2026, 21:31 UTC

Notícias Principais

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

1 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

1 de abr. de 2026, 20:38 UTC

Ganhos

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 de abr. de 2026, 20:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 de abr. de 2026, 20:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 de abr. de 2026, 20:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 de abr. de 2026, 20:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 de abr. de 2026, 20:07 UTC

Conversa de Mercado

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 de abr. de 2026, 20:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

78.18% parte superior

Previsão para 12 meses

Média 24.5 USD  78.18%

Máximo 32 USD

Mínimo 17.5 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

4

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

163 / 349 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat